ResMed Announces Participation in the 23rd Annual Macquarie Australia Conference
ResMed (NYSE: RMD) announced that CFO Brett Sandercock will present virtually at the Macquarie Australia Conference on May 5, 2021, at 8:45 a.m. AEST.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ResMed (NYSE: RMD) announced that CFO Brett Sandercock will present virtually at the Macquarie Australia Conference on May 5, 2021, at 8:45 a.m. AEST. This event will be accessible via video webcast, with a replay available for Macquarie clients 24 hours post-event until May 26, 2021. ResMed is known for its innovative digital health technologies and cloud-connected devices aimed at improving care for chronic diseases like sleep apnea and COPD, effectively transforming healthcare delivery worldwide.
Positive
- CFO will present at a major conference, potentially increasing investor interest.
- Company's commitment to innovative healthcare solutions may enhance long-term growth prospects.
Negative
- None.
Details
News Market Reaction – RMD
The recorded move for RMD in the trading session of this news was -0.10%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Wednesday, May 5, 2021, beginning at approximately 8:45 a.m. (Australian Eastern Standard Time) via video webcast.
More information about this event, including access to the live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available to Macquarie clients approximately 24 hours after the live webcast ends and will be accessible through May 26, 2021.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media | ||
| Amy Wakeham | Jayme Rubenstein | ||
| +1 858.836.5000 | +1 858.836.6798 | ||
| investorrelations@resmed.com | news@resmed.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.